Epigenetic silencing of the human NOS2 gene: Rethinking the role of nitric oxide in human macrophage inflammatory responses

Journal of Immunology

Volumn 192, Issue 5, 2014, Pages 2326-2338

  Gross, Thomas J ^a   Kremens, Karol ^a   Powers, Linda S ^a   Brink, Brandi ^a   Knutson, Tina ^a   Domann, Frederick E ^a   Philibert, Robert A ^a   Milhem, Mohammed M ^a   Monick, Martha M ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; CPG DINUCLEOTIDE; DINUCLEOTIDE; DNA; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE; TRICHOSTATIN A; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CHROMATIN; CHROMATIN IMMUNOPRECIPITATION; CONFORMATION; CONTROLLED STUDY; DEMETHYLATION; DNA MODIFICATION; EPIGENETIC REPRESSION; GENE EXPRESSION; GENE LOCUS; GENE SILENCING; HISTONE METHYLATION; HUMAN; HUMAN CELL; HUMAN VERSUS ANIMAL COMPARISON; INFLAMMATION; MACROPHAGE; MONOCYTE; MOUSE; NONHUMAN; NOS2 GENE; NUCLEOTIDE MOTIF; PRIORITY JOURNAL; PROMOTER REGION; TRANSCRIPTION INITIATION SITE;

ANIMALS; CELL LINE; CPG ISLANDS; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; GENE SILENCING; GENETIC LOCI; HUMANS; INFLAMMATION; MACROPHAGES; MALE; MICE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; SPECIES SPECIFICITY;

EID: 84896508960     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1301758     Document Type: Article

References (78)

1. Rubins, J. B. 2003. Alveolar macrophages: wielding the double-edged sword of inflammation. Am. J. Respir. Crit. Care Med. 167: 103-104.
2. Sibille, Y., and H. Y. Reynolds. 1990. Macrophages and polymorphonuclear neutrophils in lung defense and injury. Am. Rev. Respir. Dis. 141: 471-501.
3. Hanano, R., and S. H. Kaufmann. 1995. Nitric oxide production and mycobacterial growth inhibition by murine alveolar macrophages: the sequence of rIFN-gamma stimulation and Mycobacterium bovis BCG infection determines macrophage activation. Immunol. Lett. 45: 23-27.
4. Miles, P. R., L. Bowman, A. Rengasamy, and L. Huffman. 1998. Constitutive nitric oxide production by rat alveolar macrophages. Am. J. Physiol. 274: L360-L368.
5. Farley, K. S., L. F. Wang, H. M. Razavi, C. Law, M. Rohan, D. G. McCormack, and S. Mehta. 2006. Effects of macrophage inducible nitric oxide synthase in murine septic lung injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 290: L1164-L1172.
6. Skerrett, S. J., and T. R. Martin. 1996. Roles for tumor necrosis factor alpha and nitric oxide in resistance of rat alveolar macrophages to Legionella pneumophila. Infect. Immun. 64: 3236-3243.
7. MacMicking, J. D., C. Nathan, G. Hom, N. Chartrain, D. S. Fletcher, M. Trumbauer, K. Stevens, Q. W. Xie, K. Sokol, N. Hutchinson, et al. 1995. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 81: 641-650.
8. Anthony, L. S., P. J. Morrissey, and F. E. Nano. 1992. Growth inhibition of Francisella tularensis live vaccine strain by IFN-gamma-Activated macrophages is mediated by reactive nitrogen intermediates derived from L-Arginine metabolism. J. Immunol. 148: 1829-1834.
9. Albina, J. E. 1995. On the expression of nitric oxide synthase by human macrophages: why no NO? J. Leukoc. Biol. 58: 643-649.
10. Jungi, T. W., H. Adler, B. Adler, M. Thöny, M. Krampe, and E. Peterhans. 1996. Inducible nitric oxide synthase of macrophages: present knowledge and evidence for species-specific regulation. Vet. Immunol. Immunopathol. 54: 323-330.
11. Schneemann, M., G. Schoedon, S. Hofer, N. Blau, L. Guerrero, and A. Schaffner. 1993. Nitric oxide synthase is not a constituent of the antimicrobial armature of human mononuclear phagocytes. J. Infect. Dis. 167: 1358-1363.
12. Denis, M. 1994. Human monocytes/macrophages: NO or no NO? J. Leukoc. Biol. 55: 682-684.
13. Amin, A. R., M. Attur, P. Vyas, J. Leszczynska-Piziak, D. Levartovsky, J. Rediske, R. M. Clancy, K. A. Vora, and S. B. Abramson. 1995-1996. Expression of nitric oxide synthase in human peripheral blood mononuclear cells and neutrophils. J. Inflamm. 47: 190-205.
14. Bermudez, L. E. 1993. Differential mechanisms of intracellular killing of Mycobacterium avium and Listeria monocytogenes by activated human and murine macrophages: the role of nitric oxide. Clin. Exp. Immunol. 91: 277-281.
15. Nicholson, S., Mda. G. Bonecini-Almeida, J. R. Lapa e Silva, C. Nathan, Q. W. Xie, R. Mumford, J. R. Weidner, J. Calaycay, J. Geng, N. Boechat, et al. 1996. Inducible nitric oxide synthase in pulmonary alveolar macrophages from patients with tuberculosis. J. Exp. Med. 183: 2293-2302.
16. Nozaki, Y., Y. Hasegawa, S. Ichiyama, I. Nakashima, and K. Shimokata. 1997. Mechanism of nitric oxide-dependent killing of Mycobacterium bovis BCG in human alveolar macrophages. Infect. Immun. 65: 3644-3647.
17. Rich, E. A., M. Torres, E. Sada, C. K. Finegan, B. D. Hamilton, and Z. Toossi. 1997. Mycobacterium tuberculosis (MTB)-stimulated production of nitric oxide by human alveolar macrophages and relationship of nitric oxide production to growth inhibition of MTB. Tuber. Lung Dis. 78: 247-255.
18. Saleh, D., P. J. Barnes, and A. Giaid. 1997. Increased production of the potent oxidant peroxynitrite in the lungs of patients with idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 155: 1763-1769.
19. Yu, W., D. Gius, P. Onyango, K. Muldoon-Jacobs, J. Karp, A. P. Feinberg, and H. Cui. 2008. Epigenetic silencing of tumour suppressor gene p15 by its antisense RNA. Nature 451: 202-206.
20. Bastow, R., J. S. Mylne, C. Lister, Z. Lippman, R. A. Martienssen, and C. Dean. 2004. Vernalization requires epigenetic silencing of FLC by histone methylation. Nature 427: 164-167.
21. Toyota, M., H. Suzuki, Y. Sasaki, R. Maruyama, K. Imai, Y. Shinomura, and T. Tokino. 2008. Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer. Cancer Res. 68: 4123-4132.
22. Chen, Z. J., and C. S. Pikaard. 1997. Epigenetic silencing of RNA polymerase I transcription: a role for DNA methylation and histone modification in nucleolar dominance. Genes Dev. 11: 2124-2136.
23. Razin, A. 1998. CpG methylation, chromatin structure and gene silencing: a three-way connection. EMBO J. 17: 4905-4908.
24. Sandoval, J., H. Heyn, S. Moran, J. Serra-Musach, M. A. Pujana, M. Bibikova, and M. Esteller. 2011. Validation of a DNA methylation microarray for 450,000 CpG sites in the human genome. Epigenetics 6: 692-702.
25. Baylin, S. B., and J. E. Ohm. 2006. Epigenetic gene silencing in cancer: a mechanism for early oncogenic pathway addiction? Nat. Rev. Cancer 6: 107-116.
26. Mette, M. F., W. Aufsatz, J. Van der Winden, M. A. Matzke, and A. J. Matzke. 2000. Transcriptional silencing and promoter methylation triggered by doublestranded RNA. EMBO J. 19: 5194-5201.
27. Herman, J. G., and S. B. Baylin. 2003. Gene silencing in cancer in association with promoter hypermethylation. N. Engl. J. Med. 349: 2042-2054.
28. Belinsky, S. A. 2005. Silencing of genes by promoter hypermethylation: key event in rodent and human lung cancer. Carcinogenesis 26: 1481-1487.
29. Sarkar, S., A. L. Abujamra, J. E. Loew, L. W. Forman, S. P. Perrine, and D. V. Faller. 2011. Histone deacetylase inhibitors reverse CpG methylation by regulating DNMT1 through ERK signaling. Anticancer Res. 31: 2723-2732.
30. Jones, P. L., G. J. Veenstra, P. A. Wade, D. Vermaak, S. U. Kass, N. Landsberger, J. Strouboulis, and A. P. Wolffe. 1998. Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat. Genet. 19: 187-191.
31. Fuks, F., P. J. Hurd, D. Wolf, X. Nan, A. P. Bird, and T. Kouzarides. 2003. The methyl-CpG-binding protein MeCP2 links DNA methylation to histone methylation. J. Biol. Chem. 278: 4035-4040.
32. Ghoshal, K., J. Datta, S. Majumder, S. Bai, X. Dong, M. Parthun, and S. T. Jacob. 2002. Inhibitors of histone deacetylase and DNA methyltransferase synergistically activate the methylated metallothionein I promoter by activating the transcription factor MTF-1 and forming an open chromatin structure. Mol. Cell. Biol. 22: 8302-8319.
33. Pryzbylkowski, P., O. Obajimi, and J. C. Keen. 2008. Trichostatin A and 5 Aza-29 deoxycytidine decrease estrogen receptor mRNA stability in ER positive MCF7 cells through modulation of HuR. Breast Cancer Res. Treat. 111: 15-25.
34. Chai, G., L. Li, W. Zhou, L. Wu, Y. Zhao, D. Wang, S. Lu, Y. Yu, H. Wang, M. A. McNutt, et al. 2008. HDAC inhibitors act with 5-Aza-29-deoxycytidine to inhibit cell proliferation by suppressing removal of incorporated abases in lung cancer cells. PLoS One 3: e2445.
35. Flaherty, D. M., M. M. Monick, and S. L. Hinde. 2006. Human alveolar macrophages are deficient in PTEN: the role of endogenous oxidants. J. Biol. Chem. 281: 5058-5064.
36. Tsikas, D. 2007. Analysis of nitrite and nitrate in biological fluids by assays based on the Griess reaction: appraisal of the Griess reaction in the L-Arginine/ nitric oxide area of research. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 851: 51-70.
37. Dustin, M. L., R. Rothlein, A. K. Bhan, C. A. Dinarello, and T. A. Springer. 1986. Induction by IL 1 and interferon-gamma: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J. Immunol. 137: 245-254.
38. Kovarik, P., D. Stoiber, M. Novy, and T. Decker. 1998. Stat1 combines signals derived from IFN-gamma and LPS receptors during macrophage activation. EMBO J. 17: 3660-3668.
39. Brenet, F., M. Moh, P. Funk, E. Feierstein, A. J. Viale, N. D. Socci, and J. M. Scandura. 2011. DNA methylation of the first exon is tightly linked to transcriptional silencing. PLoS One 6: e14524.
40. Bruniquel, D., and R. H. Schwartz. 2003. Selective, stable demethylation of the interleukin-2 gene enhances transcription by an active process. Nat. Immunol. 4: 235-240.
41. Barski, A., S. Cuddapah, K. Cui, T.-Y. Roh, D. E. Schones, Z. Wang, G. Wei, I. Chepelev, and K. Zhao. 2007. High-resolution profiling of histone methylations in the human genome. Cell 129: 823-837.
42. Thurman, R. E., E. Rynes, R. Humbert, J. Vierstra, M. T. Maurano, E. Haugen, N. C. Sheffield, A. B. Stergachis, H. Wang, B. Vernot, et al. 2012. The accessible chromatin landscape of the human genome. Nature 489: 75-82.
43. Chan, G. C., J. E. Fish, I. A. Mawji, D. D. Leung, A. C. Rachlis, and P. A. Marsden. 2005. Epigenetic basis for the transcriptional hyporesponsiveness of the human inducible nitric oxide synthase gene in vascular endothelial cells. J. Immunol. 175: 3846-3861.
44. Saunthararajah, Y., C. A. Hillery, D. Lavelle, R. Molokie, L. Dorn, L. Bressler, S. Gavazova, Y. H. Chen, R. Hoffman, and J. DeSimone. 2003. Effects of 5-Aza-29-deoxycytidine on fetal hemoglobin levels, red cell adhesion, and hematopoietic differentiation in patients with sickle cell disease. Blood 102: 3865-3870.
45. Seok, J., H. S. Warren, A. G. Cuenca, M. N. Mindrinos, H. V. Baker, W. Xu, D. R. Richards, G. P. McDonald-Smith, H. Gao, L. Hennessy, et al; Inflammation and Host Response to Injury, Large Scale Collaborative Research Program. 2013. Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc. Natl. Acad. Sci. USA 110: 3507-3512.
46. Weinberg, J. B., M. A. Misukonis, P. J. Shami, S. N. Mason, D. L. Sauls, W. A. Dittman, E. R. Wood, G. K. Smith, B. McDonald, K. E. Bachus, et al. 1995. Human mononuclear phagocyte inducible nitric oxide synthase (iNOS): analysis of iNOS mRNA, iNOS protein, biopterin, and nitric oxide production by blood monocytes and peritoneal macrophages. Blood 86: 1184-1195.
47. Brett, S. J., and T. W. Evans. 1998. Measurement of endogenous nitric oxide in the lungs of patients with the acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 157: 993-997.
48. Smith, A. D., J. O. Cowan, K. P. Brassett, G. P. Herbison, and D. R. Taylor. 2005. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N. Engl. J. Med. 352: 2163-2173.
49. Moodley, Y. P., R. Chetty, and U. G. Lalloo. 1999. Nitric oxide levels in exhaled air and inducible nitric oxide synthase immunolocalization in pulmonary sarcoidosis. Eur. Respir. J. 14: 822-827.
50. Maziak, W., S. Loukides, S. Culpitt, P. Sullivan, S. A. Kharitonov, and P. J. Barnes. 1998. Exhaled nitric oxide in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 157: 998-1002.
51. Yang, G. G., and Y. H. Hsu. 2005. Nitric oxide production and immunoglobulin deposition in leptospiral hemorrhagic respiratory failure. J. Formos. Med. Assoc. 104: 759-763.
52. Kristof, A. S., P. Goldberg, V. Laubach, and S. N. Hussain. 1998. Role of inducible nitric oxide synthase in endotoxin-induced acute lung injury. Am. J. Respir. Crit. Care Med. 158: 1883-1889.
53. Lang, J. D., Jr., P. Chumley, J. P. Eiserich, A. Estevez, T. Bamberg, A. Adhami, J. Crow, and B. A. Freeman. 2000. Hypercapnia induces injury to alveolar epithelial cells via a nitric oxide-dependent pathway. Am. J. Physiol. Lung Cell. Mol. Physiol. 279: L994-L1002.
54. Kobayashi, H., R. Hataishi, H. Mitsufuji, M. Tanaka, M. Jacobson, T. Tomita, W. M. Zapol, and R. C. Jones. 2001. Antiinflammatory properties of inducible nitric oxide synthase in acute hyperoxic lung injury. Am. J. Respir. Cell Mol. Biol. 24: 390-397.
55. Kubes, P., M. Suzuki, and D. N. Granger. 1991. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc. Natl. Acad. Sci. USA 88: 4651-4655.
56. Aston, C., W. N. Rom, A. T. Talbot, and J. Reibman. 1998. Early inhibition of mycobacterial growth by human alveolar macrophages is not due to nitric oxide. Am. J. Respir. Crit. Care Med. 157: 1943-1950.
57. Hickman-Davis, J. M., P. O'Reilly, I. C. Davis, J. Peti-Peterdi, G. Davis, K. R. Young, R. B. Devlin, and S. Matalon. 2002. Killing of Klebsiella pneumoniae by human alveolar macrophages. Am. J. Physiol. Lung Cell. Mol. Physiol. 282: L944-L956.
58. Weinberg, J. B. 1998. Nitric oxide production and nitric oxide synthase type 2 expression by human mononuclear phagocytes: a review. Mol. Med. 4: 557-591.
59. Bukrinsky, M. I., H. S. Nottet, H. Schmidtmayerova, L. Dubrovsky, C. R. Flanagan, M. E. Mullins, S. A. Lipton, and H. E. Gendelman. 1995. Regulation of nitric oxide synthase activity in human immunodeficiency virus type 1 (HIV-1)-infected monocytes: implications for HIV-Associated neurological disease. J. Exp. Med. 181: 735-745.
60. Schneemann, M., and G. Schoeden. 2007. Macrophage biology and immunology: man is not a mouse. J. Leukoc. Biol. 81: 579-, discussion 580.
61. Schneemann, M., and G. Schoedon. 2002. Species differences in macrophage NO production are important. Nat. Immunol. 3: 102.
62. Saze, H., O. Mittelsten Scheid, and J. Paszkowski. 2003. Maintenance of CpG methylation is essential for epigenetic inheritance during plant gametogenesis. Nat. Genet. 34: 65-69.
63. Bird, A. 2002. DNA methylation patterns and epigenetic memory. Genes Dev. 16: 6-21.
64. Jones, P. A., and D. Takai. 2001. The role of DNA methylation in mammalian epigenetics. Science 293: 1068-1070.
65. Takai, D., and P. A. Jones. 2002. Comprehensive analysis of CpG islands in human chromosomes 21 and 22. Proc. Natl. Acad. Sci. USA 99: 3740-3745.
66. Hashimoto, K., M. Otero, K. Imagawa, M. C. De Andrés, J. M. Coico, H. I. Roach, R. O. Oreffo, K. B. Marcu, and M. B. Goldring. 2013. Regulated transcription of human matrix metalloproteinase 13 (MMP13) and interleukin-1b (IL1B) genes in chondrocytes depends on methylation of specific proximal promoter CpG sites. J. Biol. Chem. 288: 10061-10072.
67. El Gazzar, M., B. K. Yoza, X. Chen, J. Hu, G. A. Hawkins, and C. E. McCall. 2008. G9a and HP1 couple histone and DNA methylation to TNFalpha transcription silencing during endotoxin tolerance. J. Biol. Chem. 283: 32198-32208.
68. Berkley, A. M., D. W. Hendricks, K. B. Simmons, and P. J. Fink. 2013. Recent thymic emigrants and mature naive T cells exhibit differential DNA methylation at key cytokine loci. J. Immunol. 190: 6180-6186.
69. Northrop, J. K., R. M. Thomas, A. D. Wells, and H. Shen. 2006. Epigenetic remodeling of the IL-2 and IFN-gamma loci in memory CD8 T cells is influenced by CD4 T cells. J. Immunol. 177: 1062-1069.
70. Williams, C. L., M. M. Schilling, S. H. Cho, K. Lee, M. Wei, Aditi, and M. Boothby. 2013. STAT4 and T-bet are required for the plasticity of IFN-g expression across Th2 ontogeny and influence changes in Ifng promoter DNA methylation. J. Immunol. 191: 678-687.
71. Robert, M.-F., S. Morin, N. Beaulieu, F. Gauthier, I. C. Chute, A. Barsalou, and A. R. MacLeod. 2003. DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells. Nat. Genet. 33: 61-65.
72. Denis, H., M. N. Ndlovu, and F. Fuks. 2011. Regulation of mammalian DNA methyltransferases: a route to new mechanisms. EMBO Rep. 12: 647-656.
73. Narayan, G., C. Goparaju, H. Arias-Pulido, A. M. Kaufmann, A. Schneider, M. Dürst, M. Mansukhani, B. Pothuri, and V. V. Murty. 2006. Promoter hypermethylation-mediated inactivation of multiple Slit-Robo pathway genes in cervical cancer progression. Mol. Cancer 5: 16.
74. Guo, D. L., J. Zhang, S. T. Yuen, W. Y. Tsui, A. S. Y. Chan, C. Ho, J. Ji, S. Y. Leung, and X. Chen. 2006. Reduced expression of EphB2 that parallels invasion and metastasis in colorectal tumours. Carcinogenesis 27: 454-464.
75. Jung, J. Y., R. Madan-Lala, M. Georgieva, J. Rengarajan, C. D. Sohaskey, F. C. Bange, and C. M. Robinson. 2013. The intracellular environment of human macrophages that produce nitric oxide promotes growth of mycobacteria. Infect. Immun. 81: 3198-3209.
76. Mattila, J. T., O. O. Ojo, D. Kepka-Lenhart, S. Marino, J. H. Kim, S. Y. Eum, L. E. Via, C. E. Barry, III, E. Klein, D. E. Kirschner, et al. 2013. Microenvironments in tuberculous granulomas are delineated by distinct populations of macrophage subsets and expression of nitric oxide synthase and arginase isoforms. J. Immunol. 191: 773-784.
77. Brindicci, C., S. A. Kharitonov, M. Ito, M. W. Elliott, J. C. Hogg, P. J. Barnes, and K. Ito. 2010. Nitric oxide synthase isoenzyme expression and activity in peripheral lung tissue of patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 181: 21-30.
78. Raza, M. W., S. D. Essery, D. M. Weir, M. M. Ogilvie, R. A. Elton, and C. C. Blackwell. 1999. Infection with respiratory syncytial virus and watersoluble components of cigarette smoke alter production of tumour necrosis factor alpha and nitric oxide by human blood monocytes. FEMS Immunol. Med. Microbiol. 24: 387-394.